查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
载体筛查市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按筛查类型、按技术、按适应症、按终端用户、按公司和按地区分类
市场调查报告书
商品编码
1289643

载体筛查市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按筛查类型、按技术、按适应症、按终端用户、按公司和按地区分类

Carrier Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Screening Type, By Technology, By Indication, By End User, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在2023-2027年的预测期内，全球携带者筛查市场预计将出现令人印象深刻的增长。主要因素包括遗传病的发生率不断增加，对早期检测和预防的重视程度不断提高，以及基因组学领域的技术发展，这些都在推动着市场的增长。遗传病是由于正常DNA序列的突变而引起的疾病。载体筛查是一种有助于了解孩子患有遗传性疾病的风险的测试。它确定一个健康人是否含有遗传病的隐性基因，如镰状细胞病、囊性纤维化和其他。支持市场增长的其他因素有：政府对研究和开发活动的投资增加，新的携带者筛查测试的大量发布和批准的增加，全球出生率的增加，对个性化医疗的关注增加，人口中携带者筛查意识的增加，产妇年龄的增加，大规模基因测试项目的可用性，以及染色体疾病的高发病率。

遗传性疾病发病率的上升

基因或染色体突变导致的遗传性疾病和胎儿染色体异常的发病率上升，促进了全球市场的增长。例如，在美国，遗传性疾病是新生儿死亡的主要原因，占每年婴儿死亡率的近20%。遗传性疾病，如囊性纤维化、Tay-Sachs病和镰状细胞贫血症，是由于父母存在可遗传的基因条件，可能会被后代继承。根据世界卫生组织（WHO）的数据，在2019年，大约有2-5%的婴儿患有遗传病或染色体异常。由于新生儿残疾的发生率越来越高，产前检测需求的激增正在推动市场的增长。

对复杂遗传病的早期检测和预防的重视程度不断提高

近年来，人们对遗传性疾病有了更多的了解，这使他们能够计划并更好地照顾他们的婴儿。城市父母越来越倾向于推迟生育，母亲的平均年龄也越来越高，导致怀孕并发症，这是促进市场增长的一个因素。早期检测有助于夫妻双方在怀孕的早期阶段了解孩子患有遗传病或疾病的风险。因此，对早期检测和预防复杂的遗传性疾病的日益重视，正在推动全球市场的增长。政府和非政府组织为早期携带者筛查采取了各种倡议。例如，在2018年，迪拜卫生当局推出了 "第一步新生儿筛查"。

技术进步推动市场增长。

基因组学领域采用先进技术的增加正在增强市场的增长。由于载体筛选方法的技术进步，测试技术正变得更加可靠和方便。例如，2022年，美国科学产品供应商赛默飞世尔科技公司宣布推出基于NGS的测试套件，这是一种单一解决方案的载体筛选方法，有助于扫描遗传疾病，包括基因表达。

可用的定制产品

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

  • 对其他市场参与者（最多5家）的详细分析和剖析。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球载体筛查市场的影响

第五章：客户的声音

第六章：全球载体筛查市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按类型（扩大的携带者筛查 v/ 目标癌症筛查）
    • 按筛查类型（产前载体检测 v/ 孕前载体筛查）
    • 按技术分类（下一代测序、聚合酶链式反应、微阵列、其他）
    • 按适应症（囊性纤维化、唐氏综合症、地中海贫血、泰-萨克斯病、亨廷顿病、镰状细胞性贫血、其他）
    • 按终端用户（医院和诊所、参考实验室、其他）分类
    • 按地区
    • 按公司分类（2021年）
  • 市场地图

第七章：北美载体筛查市场前景

  • 市场规模和预测
    • 按价值分类
  • 市场份额和预测
    • 按类型
    • 按筛查类型
    • 按技术分类
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第8章：欧洲载体筛查市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按筛查类型
    • 按技术分类
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区载体筛查市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按筛查类型
    • 按技术分类
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美载体筛查市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按筛查类型
    • 按技术分类
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲载体筛查市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按类型
    • 按筛查类型
    • 按技术分类
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 载体筛查
    • 沙特阿拉伯载体筛查
    • 阿联酋的载体筛查

第十二章 ：市场动态

  • 驱动因素
  • 挑战

第十三章 ：市场趋势和发展

第十四章：竞争格局（包括SWOT分析）

  • Eurofins Scientific, Inc.
  • Fulgent Genetics, Inc.
  • CENTOGENE N.V.
  • Invitae公司
  • Illumina, Inc.
  • Gene by Gene, Ltd. (基因公司)
  • 美国实验室公司控股
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc.

第十五章：战略建议

简介目录
Product Code: 13043

The global carrier screening market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments in research and developments activities by the government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.

Rising Prevalence of Genetic Diseases

The rising incidences of genetic disorders and fetal chromosomal anomalies due to mutation in genes or chromosomes are bolstering the growth of the market globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia occur due to inheritable genetic conditions present in parents, which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.

Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders

In recent years, people have become more aware of genetic disorders, which enables them to plan and take better care of their babies. The growing inclination among urban parents to delay childbearing and the higher average age of mothers lead to pregnancy complications, which is a contributing factor to facilitating the growth of the market. Early detection helps couples to know the risk of having a child with genetic diseases or disorders in an early stage of pregnancy. Thus, the rising focus on early detection and prevention of complex genetic disorders is fueling the growth of the market globally. Various initiatives are taken by government and non-government organizations for early carrier screening. For instance, in 2018, "Step One Newborn Screening" was introduced by the Dubai health authority.

Technological Advancements fuel the Market Growth.

The rise in the adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of an NGS-based test kit, which is a type of carrier screening approach in single solution that assists in scanning genetic disorders, including gene expression.

Market Segmentation

The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down's syndrome, thalassemia, tay sachs disease, Huntington's disease, sickle cell anemia, and others. Based on end-user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.

Market Players

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.

Report Scope

In this report, global carrier screening market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Carrier Screening Market, By Type:

  • Expanded Carrier Screening
  • Targeted Cancer Screening

Carrier Screening Market, By Screening Type:

  • Prenatal Carrier Testing
  • Preconception Carrier Screening

Carrier Screening Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

Carrier Screening Market, By Indication:

  • Cystic Fibrosis
  • Down's Syndrome
  • Thalassemia
  • Tay-Sachs Disease
  • Huntington's Disease
  • Sickle Cell Anemia
  • Others

Carrier Screening Market, By End User:

  • Hospitals & Clinics
  • Reference Laboratories
  • Others

Carrier Screening Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Carrier Screening Market

5. Voice of Customer

6. Global Carrier Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)
    • 6.2.2. By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)
    • 6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)
    • 6.2.4. By Indication (Cystic Fibrosis, Down's Syndrome, Thalassemia, Tay-Sachs Disease, Huntington's Disease, Sickle Cell Anemia, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Reference Laboratories, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Carrier Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Screening Type
    • 7.2.3. By Technology
    • 7.2.4. By Indication
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Carrier Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Screening Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Carrier Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Screening Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Carrier Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Screening Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By End User

8. Europe Carrier Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Screening Type
    • 8.2.3. By Technology
    • 8.2.4. By Indication
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Carrier Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Screening Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Carrier Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Screening Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Carrier Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Screening Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Carrier Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Screening Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Carrier Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Screening Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By End User

9. Asia-Pacific Carrier Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Screening Type
    • 9.2.3. By Technology
    • 9.2.4. By Indication
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Carrier Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Screening Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By End User
    • 9.3.2. India Carrier Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Screening Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Carrier Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Screening Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Carrier Screening Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Screening Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Indication
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Carrier Screening Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Screening Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Indication
        • 9.3.5.2.5. By End User

10. South America Carrier Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Screening Type
    • 10.2.3. By Technology
    • 10.2.4. By Indication
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Carrier Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Screening Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Carrier Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Screening Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Carrier Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Screening Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By End User

11. Middle East and Africa Carrier Screening Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Screening Type
    • 11.2.3. By Technology
    • 11.2.4. By Indication
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Carrier Screening Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Screening Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Indication
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Carrier Screening Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Screening Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Indication
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Carrier Screening Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Screening Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Indication
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis)

  • 14.1. Eurofins Scientific, Inc.
  • 14.2. Fulgent Genetics, Inc.
  • 14.3. CENTOGENE N.V.
  • 14.4. Invitae Corporation
  • 14.5. Illumina, Inc.
  • 14.6. Gene by Gene, Ltd.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. Natera, Inc.
  • 14.9. Myriad Genetics, Inc.
  • 14.10. Quest Diagnostics, Inc.

15. Strategic Recommendations